Mechanisms of Cytokinesis
细胞分裂的机制
基本信息
- 批准号:10675754
- 负责人:
- 金额:$ 46.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-08-02 至 2026-07-31
- 项目状态:未结题
- 来源:
- 关键词:ActomyosinAddressAnaphaseBiological AssayC-terminalCDC2 geneCaenorhabditis elegansCell CycleCell divisionCell membraneCellsCentrosomeChromosome SegregationChromosomesCompetenceComplementComplexCyclin BCytokinesisCytoplasmDNA biosynthesisDataDiffusionDimensionsEmbryoFailureFamilyGTPase-Activating ProteinsGenetic CodeGenomicsGoalsGuanine Nucleotide Exchange FactorsGuanosine TriphosphateGuanosine Triphosphate PhosphohydrolasesHumanInvestmentsKinesinLifeMalignant NeoplasmsMeasuresMediatingMediatorMicrotubule BundleMicrotubulesMitosisMitoticMitotic spindleModelingMolecularMonitorMothersMutationN-terminalNuclearOrganismPLK1 genePatternPhasePhosphorylationPhosphotransferasesPopulationPositioning AttributeProcessProteasome InhibitionProteinsRoleSignal TransductionSpecific qualifier valueSystemTP53 geneTertiary Protein StructureTestingTimeUp-RegulationWorkaurora kinase Achemotherapeutic agentconstrictiondaughter celldimergenome integrityinhibitorinterestpermissivenesspreservationpreventrhoscreening
项目摘要
PROJECT SUMMARY
After the chromosomes are segregated by the microtubule-based mitotic spindle, cytokinesis completes cell
division, partitioning the contents of the mother cell to the two daughter cells. Cytokinesis is accomplished by
constriction of an acto-myosin contractile ring that forms on the cortex in an equatorial band encircling the cell
equator. Cytokinesis failure generates tetraploid cells that are a common intermediate in the genesis of cancers.
Upregulation and mutation of cytokinesis regulators has also been implicated in different cancers, and inhibitors
targeting cytokinesis are of interest as potential chemotherapeutic agents, motivating efforts to understand the
mechanisms that pattern cortical contractility during cytokinesis. To ensure that each daughter cell receives an
equivalent genomic complement, the position of the contractile ring is specified by the anaphase spindle. The
spindle sends two superimposed signals to the cortex: (1) a positive signal promoting contractile ring assembly
that is generated by set of bundled microtubules, called the central spindle, that forms between the separating
chromosomes, and (2) a negative signal generated by the microtubule asters that suppresses the contractility of
the non-equatorial cortex. The proposed work focuses on the molecular basis for these two signals that
collectively direct contractile ring assembly. A central component of the positive signal promoting contractile ring
assembly is centralspindlin, a tetrameric complex formed by a dimer of kinesin-6 and a dimer of CYK4.
Centralspindlin is phosphorylated by the mitotic kinase PLK1, which concentrates on the central spindle; it
subsequently diffuses to the adjacent plasma membrane where, through mechanisms that remain largely
unclear, its CYK4 subunit engages with and activates the ECT2 guanine nucleotide exchange factor (GEF).
Active ECT2 in turn generates an equatorial zone enriched for the master regulator of contractile ring assembly,
RhoA-GTP. In Aim 1, we address the major open question with respect to positive cytokinesis signaling: the
mechanism of ECT2 activation by centralspindlin. To understand how the microtubule asters suppress
contractility on the non-equatorial cortex, which occurs at the same time as positive signaling from the central
spindle, we developed an assay monitoring clearing of contractile ring proteins from the cell poles in the C.
elegans embryo. Using this assay, we identified Aurora A kinase as an essential mediator of aster-based
contractility suppression. In Aim 2, we build on this work to identify the Aurora A targets that mediate contractility
suppression and extend analysis of this mechanism to human cells. Aim 3 addresses an important gap in
understanding how the cell cycle state that supports contractile ring assembly is generated, and assesses
whether the duration of cytokinesis, like that of mitosis, is monitored by a p53-based mitotic stopwatch
mechanism that eliminates potentially problematic cells from the population.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Karen F Oegema其他文献
Karen F Oegema的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Karen F Oegema', 18)}}的其他基金
IDENTIFICATION OF C05C89 INTERACTING PROTEINS
C05C89 相互作用蛋白的鉴定
- 批准号:
8171386 - 财政年份:2010
- 资助金额:
$ 46.78万 - 项目类别:
POST-TRANSLATIONAL MODIFICATION OF SPD-2/5 AND SAS5/6
SPD-2/5 和 SAS5/6 的翻译后修饰
- 批准号:
8171369 - 财政年份:2010
- 资助金额:
$ 46.78万 - 项目类别:
IDENTIFICATION OF RHOGAP INTERACTING PROTEINS
RHOGAP 相互作用蛋白的鉴定
- 批准号:
8171422 - 财政年份:2010
- 资助金额:
$ 46.78万 - 项目类别:
HIGH-RESOLUTION PHENOTYPIC PROFILING BASED ON THE COMPLEX ARCHITECTURE OF THE C
基于 C 复杂结构的高分辨率表型分析
- 批准号:
8171265 - 财政年份:2010
- 资助金额:
$ 46.78万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 46.78万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 46.78万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 46.78万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 46.78万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 46.78万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 46.78万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 46.78万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 46.78万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 46.78万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 46.78万 - 项目类别:
Research Grant














{{item.name}}会员




